Montgomery County plays a central role in the Capital Region’s role as the nation’s third-largest biopharma cluster, according to a recent national industry ranking. The Capital Region, which includes Montgomery County along with surrounding jurisdictions in Maryland, Washington, D.C., and Northern Virginia, was ranked third among U.S. biopharma hubs in Genetic Engineering & Biotechnology News’ 2025 Top 10 U.S. Biopharma Clusters report, reflecting the scale of the region’s life sciences ecosystem, workforce, and concentration of research institutions and companies.
Montgomery County serves as the anchor of the region’s biopharma ecosystem, home to more than 350 life sciences companies and a large share of the region’s research, development, and manufacturing activity. Global pharmaceutical and biotechnology companies including AstraZeneca, Novavax, and United Therapeutics have a significant presence in the County, contributing to its role as a national center for drug development, vaccines, and advanced therapies. (more…)